Mycoplasma Prostatitis Treatment Guide: Antibiotic Therapy and Chinese Herbal Remedies

Mycoplasma prostatitis is an important subtype of non-bacterial prostatitis in men, accounting for about 30%–40% of cases. It is mainly caused by infections of Ureaplasma urealyticum (UU) and Mycoplasma hominis (MH) in the prostate. Since mycoplasmas lack a cell wall, they are naturally resistant to antibiotics that act on bacterial cell walls (such as penicillins and cephalosporins). In addition, they are easily transmitted through sexual contact and tend to recur when immunity declines, making clinical management significantly more challenging than bacterial prostatitis.

This condition not only causes urinary discomfort and pelvic pain but may also lead to anxiety, sexual dysfunction, and impaired quality of life due to its chronic and recurrent nature.

1. Core Symptoms of Mycoplasma Prostatitis: Highly Variable and Require Precise Identification

Symptoms are often non-specific, and about 20% of patients may be asymptomatic. When present, the clinical picture usually combines urogenital discomfort and systemic/psychological symptoms, which can be classified into four categories:

(1) Urethral Symptoms: Early Warning Signs of Infection

Urination abnormalities: Frequency (≥8 times/day, ≥2 times/night), urgency (inability to hold urine), dysuria (burning/stinging during urination), and in some cases, weak stream or incomplete emptying.

Discharge: Small amounts of whitish, mucoid (non-purulent) secretion may appear at the urethral meatus, especially in the morning (“gluing” phenomenon). This differs from the purulent discharge seen in gonococcal urethritis.

(2) Prostate/Pelvic Pain: Wide Distribution, Easily Misdiagnosed

Core pain: Perineal pain or heaviness or lower abdomen, often worsened by sitting or cycling and relieved by standing.

Radiating pain: May spread to the testes, groin, sacral area, or cause painful ejaculation.

Pain characteristics: Usually mild-to-moderate dull ache (NRS 3–5), not severe, and may be mistaken for low back strain or orchitis.

(3) Sexual Dysfunction: A Common Complication of Chronic Inflammation

Erectile dysfunction: Caused by inflammation-induced pelvic congestion or nerve compression, leading to reduced rigidity and shorter duration.

Premature ejaculation or spermatorrhea: Hypersensitivity of the prostate lowers ejaculation threshold, sometimes causing nocturnal or spontaneous semen leakage.

(4) Systemic and Psychological Symptoms: The “Invisible Burden”

Systemic: Low-grade fever (37.5–38℃), fatigue, and muscle soreness during the acute stage; minimal systemic signs in chronic phase.

Psychological: Anxiety, irritability, and insomnia affect about 50% of patients, often due to chronic symptoms, fear of infertility, or uncertainty about cure, creating a vicious cycle of “symptoms → anxiety → worsening symptoms.”

2. Standardized Treatment of Mycoplasma Prostatitis: Tailored Choices to Avoid Resistance

The core goals are eliminating mycoplasma, relieving symptoms, and preventing recurrence. Management generally includes antibiotic therapy (infection control) and traditional Chinese medicine (symptom regulation and immune support). Combining the two can improve outcomes and reduce limitations of monotherapy.

(1) Antibiotic Therapy: First-Line for Acute/Susceptible Infections

Since mycoplasma lacks a cell wall, only antibiotics that inhibit protein synthesis or DNA replication are effective. Resistance rates are increasing, especially to macrolides (>40% in some regions).

a. Prerequisite: Confirm Infection and Perform Drug Sensitivity Testing

• Prostatic fluid/urethral secretion culture and sensitivity testing is essential to identify UU/MH and guide antibiotic choice.
• Semen testing may be used if prostatic fluid is hard to obtain, also providing fertility evaluation.

b. Commonly Used Antibiotics

Quinolones (e.g., Levofloxacin):

• Mechanism: Interferes with DNA gyrase, blocking replication.
• Dosage: 0.5 g once daily, orally, for 4–6 weeks.
• Best for: Acute infection or macrolide-resistant cases with significant urinary symptoms.
• Precautions: Contraindicated under 18 years; dose adjustment required for renal impairment; long-term use may risk tendon damage.

Macrolides (e.g., Azithromycin, Clarithromycin):

• Azithromycin: 1 g orally once, followed by 0.5 g one week later. Effective against UU in young patients or those with urethritis. Possible mild GI discomfort.
• Clarithromycin: 0.5 g twice daily for 2–3 weeks. Suitable for macrolide-resistant cases or MH infection. May cause GI upset and requires caution in liver dysfunction.

c. Key Principles of Antibiotic Use

• No empirical treatment without drug sensitivity results.
• Full course therapy (minimum 3 weeks) to prevent relapse.
• Switch drugs if resistant (e.g., doxycycline for resistant strains).

(2) Traditional Chinese Medicine (TCM): Preferred for Chronic/Recurrent/Resistant Cases

In TCM, mycoplasma prostatitis falls under “turbid essence” or “stranguria” disorders, with core pathogenesis of damp-heat, blood stasis, and deficiency of spleen and kidney. Treatment emphasizes clearing heat, detoxifying, promoting blood flow, relieving pain, and supporting immunity.

Core Herbal Remedy: Diuretic and Anti-inflammatory Pill

Composition: 50+ herbs categorized into four groups:

• Heat-clearing/detoxifying (Houttuynia, Honeysuckle, Viola, Taraxacum)
• Diuretic/drain dampness (Plantago seed, Polygonum, Talc, Dianthus)
• Blood-activating/pain-relieving (Angelica, Safflower, Peach kernel)
• Tonifying (Atractylodes, Yam, Eucommia, Goji berry)

Advantages:

• Multi-target action with no drug resistance.
• Regulates overall body function, improving immunity, fertility, and sexual health.
• Safe for long-term use and suitable for patients with fertility needs.

Dosage: twice daily, 1 months as one course.

Clinical effect: 85% negativity conversion after 2–3 courses, with relapse rate <15% (vs. ~35% for antibiotics).

3. Beyond Medication: Rehabilitation and Recurrence Prevention

Even with proper treatment, recurrence risk remains >60% without lifestyle adjustments. Key strategies include:

(1) Lifestyle and Exercise

• Avoid prolonged sitting/cycling; take breaks every hour.
• Sleep before 11 p.m. and ensure 7–8 hours per night.
• Do moderate aerobic exercise (jogging, swimming, tai chi) 3–5 times per week.

(2) Diet

• Avoid spicy, alcoholic, cold, sugary, and fatty foods.
• Eat more dampness-draining foods (Coix seed, adzuki bean, winter melon).
• Supplement with zinc (oysters, lean meat, nuts).
• Increase vitamin C intake for immunity.

(3) Psychological Care

• Recognize that the disease is curable, not cancerous, and usually does not impair fertility.
• Practice relaxation techniques (meditation, music, socializing).
• Communicate openly with partners and use condoms during treatment to prevent reinfection.

(4) Regular Follow-up

• Test prostatic fluid or semen every 1–2 months during treatment.
• Monitor inflammation markers and sperm quality (if fertility is a concern).
• Continue follow-up every 3–6 months post-recovery for 1 year.

Conclusion

Mycoplasma prostatitis requires a balanced treatment approach. Over-reliance on antibiotics risks resistance, while ignoring standard therapy delays recovery.

• Acute/susceptible cases: Antibiotics as first-line, supported by short-term herbal therapy.
• Chronic/recurrent or resistant cases: TCM (e.g., Diuretic and Anti-inflammatory Pill) as the mainstay, supplemented by sensitive antibiotics when needed.

Long-term recovery depends not only on clearing the pathogen but also on symptom control, immune enhancement, lifestyle adjustment, and psychological support. With standardized treatment, most patients can achieve recovery within 3–6 months.